These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 26691296)

  • 21. Amyotrophic lateral sclerosis.
    Hardiman O; Al-Chalabi A; Chio A; Corr EM; Logroscino G; Robberecht W; Shaw PJ; Simmons Z; van den Berg LH
    Nat Rev Dis Primers; 2017 Oct; 3():17071. PubMed ID: 28980624
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advances and challenges in understanding the multifaceted pathogenesis of amyotrophic lateral sclerosis.
    Laferriere F; Polymenidou M
    Swiss Med Wkly; 2015; 145():w14054. PubMed ID: 25635517
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modeling ALS and FTD with iPSC-derived neurons.
    Lee S; Huang EJ
    Brain Res; 2017 Feb; 1656():88-97. PubMed ID: 26462653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stem cell therapy in amyotrophic lateral sclerosis.
    Meamar R; Nasr-Esfahani MH; Mousavi SA; Basiri K
    J Clin Neurosci; 2013 Dec; 20(12):1659-63. PubMed ID: 24148693
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Frontal lobe dysfunction in ALS].
    Alcaz S; Apostolski S
    Srp Arh Celok Lek; 1995; 123(9-10):266-70. PubMed ID: 17974446
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Translating biological findings into new treatment strategies for amyotrophic lateral sclerosis (ALS).
    Poppe L; Rué L; Robberecht W; Van Den Bosch L
    Exp Neurol; 2014 Dec; 262 Pt B():138-51. PubMed ID: 25017368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Experimental trials in amyotrophic lateral sclerosis: a review of recently completed, ongoing and planned trials using existing and novel drugs.
    Goyal NA; Mozaffar T
    Expert Opin Investig Drugs; 2014 Nov; 23(11):1541-51. PubMed ID: 24965719
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of 2 Loci at chromosomes 9 and 14 in a multiplex family with frontotemporal lobar degeneration and amyotrophic lateral sclerosis.
    Gijselinck I; Engelborghs S; Maes G; Cuijt I; Peeters K; Mattheijssens M; Joris G; Cras P; Martin JJ; De Deyn PP; Kumar-Singh S; Van Broeckhoven C; Cruts M
    Arch Neurol; 2010 May; 67(5):606-16. PubMed ID: 20457961
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transcranial direct current stimulation does not modulate motor cortex excitability in patients with amyotrophic lateral sclerosis.
    Munneke MA; Stegeman DF; Hengeveld YA; Rongen JJ; Schelhaas HJ; Zwarts MJ
    Muscle Nerve; 2011 Jul; 44(1):109-14. PubMed ID: 21674525
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interhemispheric connectivity in amyotrophic lateral sclerosis: A near-infrared spectroscopy and diffusion tensor imaging study.
    Kopitzki K; Oldag A; Sweeney-Reed CM; Machts J; Veit M; Kaufmann J; Hinrichs H; Heinze HJ; Kollewe K; Petri S; Mohammadi B; Dengler R; Kupsch AR; Vielhaber S
    Neuroimage Clin; 2016; 12():666-672. PubMed ID: 27761397
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integrative gene-tissue microarray-based approach for identification of human disease biomarkers: application to amyotrophic lateral sclerosis.
    Kudo LC; Parfenova L; Vi N; Lau K; Pomakian J; Valdmanis P; Rouleau GA; Vinters HV; Wiedau-Pazos M; Karsten SL
    Hum Mol Genet; 2010 Aug; 19(16):3233-53. PubMed ID: 20530642
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amyotrophic Lateral Sclerosis Regional Variants (Brachial Amyotrophic Diplegia, Leg Amyotrophic Diplegia, and Isolated Bulbar Amyotrophic Lateral Sclerosis).
    Jawdat O; Statland JM; Barohn RJ; Katz JS; Dimachkie MM
    Neurol Clin; 2015 Nov; 33(4):775-85. PubMed ID: 26515621
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extra-motor abnormalities in amyotrophic lateral sclerosis: another layer of heterogeneity.
    McCombe PA; Wray NR; Henderson RD
    Expert Rev Neurother; 2017 Jun; 17(6):561-577. PubMed ID: 27983884
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Navigated transcranial magnetic stimulation in amyotrophic lateral sclerosis.
    Chervyakov AV; Bakulin IS; Savitskaya NG; Arkhipov IV; Gavrilov AV; Zakharova MN; Piradov MA
    Muscle Nerve; 2015 Jan; 51(1):125-31. PubMed ID: 25049055
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation and management of amyotrophic lateral sclerosis.
    Valadi N
    Prim Care; 2015 Jun; 42(2):177-87. PubMed ID: 25979579
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differentiation between primary lateral sclerosis and amyotrophic lateral sclerosis: examination of symptoms and signs at disease onset and during follow-up.
    Tartaglia MC; Rowe A; Findlater K; Orange JB; Grace G; Strong MJ
    Arch Neurol; 2007 Feb; 64(2):232-6. PubMed ID: 17296839
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amyotrophic lateral sclerosis.
    Jackson CE; Bryan WW
    Semin Neurol; 1998; 18(1):27-39. PubMed ID: 9562665
    [TBL] [Abstract][Full Text] [Related]  

  • 38. From Multi-Omics Approaches to Precision Medicine in Amyotrophic Lateral Sclerosis.
    Morello G; Salomone S; D'Agata V; Conforti FL; Cavallaro S
    Front Neurosci; 2020; 14():577755. PubMed ID: 33192262
    [TBL] [Abstract][Full Text] [Related]  

  • 39. System xC- is a mediator of microglial function and its deletion slows symptoms in amyotrophic lateral sclerosis mice.
    Mesci P; Zaïdi S; Lobsiger CS; Millecamps S; Escartin C; Seilhean D; Sato H; Mallat M; Boillée S
    Brain; 2015 Jan; 138(Pt 1):53-68. PubMed ID: 25384799
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Energy metabolism in amyotrophic lateral sclerosis.
    Dupuis L; Pradat PF; Ludolph AC; Loeffler JP
    Lancet Neurol; 2011 Jan; 10(1):75-82. PubMed ID: 21035400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.